FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Uhde

Research Profile

Activities & Behaviors

Panic

Disorders

Physiology

Fear
Arousal

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Bernadette M Cortese; Todd R Mitchell; matthew galloway; Kristen E Prevost; Jidong Fang; Gregory Moore; Thomas W Uhde
Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior.
Thomas W Uhde; Bernadette M Cortese; Andrei Vedeniapin
Anxiety and sleep problems: emerging concepts and theoretical treatment implications.
Dawn L Flosnik; Bernadette M Cortese; Thomas W Uhde
Cataplexy in anxious patients: is subclinical narcolepsy underrecognized in anxiety disorders?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Uhde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Bernadette M Cortese; Todd R Mitchell; matthew galloway; Kristen E Prevost; Jidong Fang; Gregory Moore; Thomas W Uhde
Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior.
Physiology & behavior 2010;99(4):445-50.
2009: Thomas W Uhde; Bernadette M Cortese; Andrei Vedeniapin
Anxiety and sleep problems: emerging concepts and theoretical treatment implications.
Current psychiatry reports 2009;11(4):269-76.
2009: Dawn L Flosnik; Bernadette M Cortese; Thomas W Uhde
Cataplexy in anxious patients: is subclinical narcolepsy underrecognized in anxiety disorders?
The Journal of clinical psychiatry 2009;70(6):810-6.
2009: Gregory Moore; Bernadette M Cortese; Debra A Glitz; Caroline Zajac-Benitez; Jorge A Quiroz; Thomas W Uhde; Wayne C Drevets; Husseini K Manji
A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
The Journal of clinical psychiatry 2009;70(5):699-705.
2009: Ravi Singareddy; Thomas W Uhde
Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder.
Journal of affective disorders 2009;112(1-3):262-6.
2007: Robert M Post; Terence A Ketter; Thomas W Uhde; James C Ballenger
Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.
CNS drugs 2007;21(1):47-71.
2006: Ravi Singareddy; Thomas W Uhde; Randall L Commissaris
Differential effects of hypocretins on noise-alone versus potentiated startle responses.
Physiology & behavior 2006;89(5):650-5.
2006: Bernadette M Cortese; Thomas W Uhde
Immobilization panic.
The American journal of psychiatry 2006;163(8):1453-4.
2005: Kinh Luan Phan; Daniel A Fitzgerald; Pradeep Nathan; Gregory Moore; Thomas W Uhde; Manuel Tancer
Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study.
Biological psychiatry 2005;57(3):210-9.
2005: Michael Bonnet; Manuel Tancer; Thomas W Uhde; Vikram K Yeragani
Effects of caffeine on heart rate and QT variability during sleep.
Depression and anxiety 2005;22(3):150-5.
2005: James L Abelson; George C Curtis; Thomas W Uhde
Twenty-four hour growth hormone secretion in patients with panic disorder.
Psychoneuroendocrinology 2005;30(1):72-9.
2004: Vikram K Yeragani; Mallika Mallavarapu; Rao K A Radhakrishna; Manuel Tancer; Thomas W Uhde
Linear and nonlinear measures of blood pressure variability: increased chaos of blood pressure time series in patients with panic disorder.
Depression and anxiety 2004;19(2):85-95.
2004: Vikram K Yeragani; Radhakrishna Rao; Manuel Tancer; Thomas W Uhde
Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report.
Neuropsychobiology 2004;49(2):53-7.
2003: Vikram K Yeragani; Manuel Tancer; Thomas W Uhde
Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder.
Psychiatry research 2003;121(2):185-96.
2003: Ravi Singareddy; Ali Moin; Lisa Spurlock; Orlena B Merritt-Davis; Thomas W Uhde
Skin picking and sleep disturbances: relationship to anxiety and need for research.
Depression and anxiety 2003;18(4):228-32.
2003: Terry M Brown; Thomas W Uhde
Sleep panic attacks: a micro-movement analysis.
Depression and anxiety 2003;18(4):214-20.
2002: Vikram K Yeragani; Manuel Tancer; Debra Glitz; Thomas W Uhde; Nagaraj Desai
Significant difference in beat-to-beat QT interval variability among different leads.
Heart disease (Hagerstown, Md.) 2002;4(6):344-8.
2002: Vikram K Yeragani; Rao K A Radhakrishna; Manuel Tancer; Thomas W Uhde
Nonlinear measures of respiration: respiratory irregularity and increased chaos of respiration in patients with panic disorder.
Neuropsychobiology 2002;46(3):111-20.
2000: Thomas W Uhde
Genetics and brain function: implications for the treatment of anxiety.
Biological psychiatry 2000;48(12):1142-3.
2000: Thomas L Rodebaugh; Dianne L Chambless; D R Terrill; M Floyd; Thomas W Uhde
Convergent, discriminant, and criterion-related validity of the Social Phobia and Anxiety Inventory.
Depression and anxiety 2000;11(1):10-4.
1998: thomas nordahl; M B Stein; C Benkelfat; WE Semple; PJ Andreason; Alan J Zametkin; Thomas W Uhde; Robert M Cohen
Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders.
Biological psychiatry 1998;44(10):998-1006.
1998: G N Gurguis; Thomas W Uhde
The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder.
Journal of psychiatric research 1998;32(1):11-7.
1997: G N Gurguis; B J Vitton; Thomas W Uhde
Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.
Psychiatry research 1997;71(1):27-39.
1997: Una D McCann; SO Slate; Marilla Geraci; D Roscow-Terrill; Thomas W Uhde
A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(3):229-37.
1997: B S Scupi; B E Benson; L B Brown; Thomas W Uhde
Rapid onset: a valid panic disorder criterion?
Depression and anxiety 1997;5(3):121-6.
1997: A S Lin; Thomas W Uhde; SO Slate; Una D McCann
Effects of intravenous caffeine administered to healthy males during sleep.
Depression and anxiety 1997;5(1):21-8.
1997: Manuel Tancer; Thomas W Uhde
Role of serotonin drugs in the treatment of social phobia.
The Journal of clinical psychiatry 1997;58 Suppl 5():50-4.
1996: Thomas W Uhde
What looks good and is good for you? The Journal Depression and Anxiety.
Anxiety 1996;2(6):255.
1995: B Black; Thomas W Uhde
Psychiatric characteristics of children with selective mutism: a pilot study.
Journal of the American Academy of Child and Adolescent Psychiatry 1995;34(7):847-56.
1994: B Black; Thomas W Uhde
Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33(7):1000-6.
1994: Thomas W Uhde
Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia.
The Journal of clinical psychiatry 1994;55 Suppl():17-27.
1994: R O Cannon; Arshed A Quyyumi; Rita A Mincemoyer; A M Stine; Richard H Gracely; W B Smith; M F Geraci; B C Black; Thomas W Uhde; Myron A Waclawiw
Imipramine in patients with chest pain despite normal coronary angiograms.
The New England journal of medicine 1994;330(20):1411-7.
1994: T M Brown; B Black; Thomas W Uhde
The sleep architecture of social phobia.
Biological psychiatry 1994;35(6):420-1.
1994: Thomas W Uhde; Manuel Tancer; C S Gelernter; B J Vittone
Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers.
Journal of affective disorders 1994;30(3):155-61.
1994: Una D McCann; S O Slate; Marilla Geraci; Thomas W Uhde
Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
Anxiety 1994;1(6):258-67.
1994: P V Nickell; Thomas W Uhde
Dose-response effects of intravenous caffeine in normal volunteers.
Anxiety 1994;1(4):161-8.
1994: Manuel Tancer; M B Stein; Thomas W Uhde
Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls.
Anxiety 1994;1(3):138-40.
1994: Mark Stork George; L C Malloy; S O Slate; Thomas W Uhde
Pilot MRI study of brain size in nervous pointer dogs.
Anxiety 1994;1(3):129-33.
1994: Thomas W Uhde; L C Malloy; B B Benson
Growth hormone response to clonidine in the nervous pointer dog model of anxiety.
Anxiety 1994;1(2):45-9.
1994: Sheldon A Steinberg; E Klein; R L Killens; Thomas W Uhde
Inherited deafness among nervous pointer dogs.
The Journal of heredity 1994;85(1):56-9.
1993: Manuel Tancer; M B Stein; Thomas W Uhde
Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
Biological psychiatry 1993;34(9):591-5.
1993: M B Stein; B Black; T M Brown; Thomas W Uhde
Lack of efficacy of the adenosine reuptake inhibitor dipyridamole in the treatment of anxiety disorders.
Biological psychiatry 1993;33(8-9):647-50.
1993: Manuel Tancer; M B Stein; B Black; Thomas W Uhde
Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
The American journal of psychiatry 1993;150(2):336-7.
1992: B Black; Thomas W Uhde
Elective mutism as a variant of social phobia.
Journal of the American Academy of Child and Adolescent Psychiatry 1992;31(6):1090-4.
1992: Marilla Geraci; Thomas W Uhde
Diurnal rhythms and symptom severity in panic disorder. A preliminary study of 24-hour changes in panic attacks, generalised anxiety, and avoidance behaviour.
The British journal of psychiatry : the journal of mental science 1992;161():512-6.
1992: B S Scupi; J D Maser; Thomas W Uhde
The National Institute of Mental Health Panic Questionnaire. An instrument for assessing clinical characteristics of panic disorder.
The Journal of nervous and mental disease 1992;180(9):566-72.
1992: B Black; Thomas W Uhde
Acute dystonia and fluoxetine.
The Journal of clinical psychiatry 1992;53(9):327.
1992: Thomas W Uhde; L C Malloy; S O Slate
Fearful behavior, body size, and serum IGF-I levels in nervous and normal pointer dogs.
Pharmacology, biochemistry, and behavior 1992;43(1):263-9.
1992: B Black; Thomas W Uhde; Manuel Tancer
Fluoxetine for the treatment of social phobia.
Journal of clinical psychopharmacology 1992;12(4):293-5.
1992: F Newman; M B Stein; J R Trettau; R Coppola; Thomas W Uhde
Quantitative electroencephalographic effects of caffeine in panic disorder.
Psychiatry research 1992;45(2):105-13.
1992: M B Stein; Manuel Tancer; Thomas W Uhde
Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects.
Archives of general psychiatry 1992;49(4):311-7.
1992: Thomas W Uhde; Manuel Tancer; David Rubinow; D B Roscow; J P Boulenger; B Vittone; G Gurguis; Marilla Geraci; B Black; Robert M Post
Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1992;6(2):101-18.
1992: Stephen Rao; O Devinsky; Jordan Grafman; M Stein; M Usman; Thomas W Uhde; W H Theodore
Viscosity and social cohesion in temporal lobe epilepsy.
Journal of neurology, neurosurgery, and psychiatry 1992;55(2):149-52.
1992: C S Gelernter; M B Stein; Manuel Tancer; Thomas W Uhde
An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder.
The Journal of clinical psychiatry 1992;53(1):23-7.
1991: E Klein; Joseph Zohar; Marilla Geraci; Dennis L Murphy; Thomas W Uhde
Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
Biological psychiatry 1991;30(10):973-84.
1991: Thomas W Uhde; Manuel Tancer; B Black; T M Brown
Phenomenology and neurobiology of social phobia: comparison with panic disorder.
The Journal of clinical psychiatry 1991;52 Suppl():31-40.
1991: C S Gelernter; Thomas W Uhde; P Cimbolic; D B Arnkoff; B J Vittone; Manuel Tancer; J J Bartko
Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
Archives of general psychiatry 1991;48(10):938-45.
1991: G N Gurguis; I N Mefford; Thomas W Uhde
Hypothalamic-pituitary-adrenocortical activity in panic disorder: relationship to plasma catecholamine metabolites.
Biological psychiatry 1991;30(5):502-6.
1991: M B Stein; J Muir-Nash; Thomas W Uhde
The QKd interval in panic disorder: an assessment of end-organ thyroid hormone responsivity.
Biological psychiatry 1991;29(12):1209-14.
1991: M B Stein; Thomas W Uhde
Endocrine, cardiovascular, and behavioral effects of intravenous protirelin in patients with panic disorder.
Archives of general psychiatry 1991;48(2):148-56.
1990: M B Stein; Thomas W Uhde
Triiodothyronine potentiation of tricyclic antidepressant treatment in patients with panic disorder.
Biological psychiatry 1990;28(12):1061-4.
1990: Thomas A Mellman; Thomas W Uhde
Patients with frequent sleep panic: clinical findings and response to medication treatment.
The Journal of clinical psychiatry 1990;51(12):513-6.
1990: D A Sklare; M B Stein; A M Pikus; Thomas W Uhde
Dysequilibrium and audiovestibular function in panic disorder: symptom profiles and test findings.
The American journal of otology 1990;11(5):338-41.
1990: G N Gurguis; Thomas W Uhde
Effect of yohimbine on plasma homovanillic acid in panic disorder patients and normal controls.
Biological psychiatry 1990;28(4):292-6.
1990: thomas nordahl; WE Semple; M Gross; Thomas A Mellman; M B Stein; P Goyer; A C King; Thomas W Uhde; Robert M Cohen
Cerebral glucose metabolic differences in patients with panic disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(4):261-72.
1990: M B Stein; Manuel Tancer; Thomas W Uhde
Major depression in patients with panic disorder: factors associated with course and recurrence.
Journal of affective disorders 1990;19(4):287-96.
1990: G N Gurguis; E Klein; I N Mefford; Thomas W Uhde
Biogenic amines distribution in the brain of nervous and normal pointer dogs. A genetic animal model of anxiety.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(4):297-303.
1990: Manuel Tancer; M B Stein; B B Bessette; Thomas W Uhde
Behavioral effects of chronic imipramine treatment in genetically nervous pointer dogs.
Physiology & behavior 1990;48(1):179-81.
1990: Manuel Tancer; M B Stein; C S Gelernter; Thomas W Uhde
The hypothalamic-pituitary-thyroid axis in social phobia.
The American journal of psychiatry 1990;147(7):929-33.
1990: Manuel Tancer; M B Stein; Thomas W Uhde
Paradoxical growth-hormone responses to thyrotropin-releasing hormone in panic disorder.
Biological psychiatry 1990;27(11):1227-30.
1990: M B Stein; Manuel Tancer; C S Gelernter; B J Vittone; Thomas W Uhde
Major depression in patients with social phobia.
The American journal of psychiatry 1990;147(5):637-9.
1990: E H Klein; T Tomai; Thomas W Uhde
Hypothalamo-pituitary-adrenal axis activity in nervous and normal pointer dogs.
Biological psychiatry 1990;27(7):791-4.
1990: Manuel Tancer; M B Stein; Thomas W Uhde
Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: a pilot study.
Biological psychiatry 1990;27(7):781-3.
1990: M B Stein; I J Heuser; Jorge L Juncos; Thomas W Uhde
Anxiety disorders in patients with Parkinson's disease.
The American journal of psychiatry 1990;147(2):217-20.
1990: Manuel Tancer; M B Stein; D E Moul; Thomas W Uhde
Normal serum cholesterol in panic disorder.
Biological psychiatry 1990;27(1):99-101.
1990: G N Gurguis; Thomas W Uhde
Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
Psychoneuroendocrinology 1990;15(3):217-24.
1990: Ehud Klein; M Geraci; Thomas W Uhde
Inefficacy of single-dose nifedipine in the treatment of phobic anxiety.
The Israel journal of psychiatry and related sciences 1990;27(2):119-23.
1990: M B Stein; Thomas W Uhde
Thyrotropin and prolactin responses to protirelin (TRH) prior to and during chronic imipramine treatment in patients with panic disorder.
Psychoneuroendocrinology 1990;15(5-6):381-9.
1990: Manuel Tancer; M B Stein; Thomas W Uhde
Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
Psychoneuroendocrinology 1990;15(4):253-9.
1989: M B Stein; P J Schmidt; David Rubinow; Thomas W Uhde
Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome.
The American journal of psychiatry 1989;146(10):1299-303.
1989: Thomas A Mellman; Thomas W Uhde
Sleep panic attacks: new clinical findings and theoretical implications.
The American journal of psychiatry 1989;146(9):1204-7.
1989: M B Stein; Thomas W Uhde
Depersonalization disorder: effects of caffeine and response to pharmacotherapy.
Biological psychiatry 1989;26(3):315-20.
1989: Robert M Post; David Rubinow; Thomas W Uhde; P P Roy-Byrne; M Linnoila; A Rosoff; R Cowdry
Dysphoric mania. Clinical and biological correlates.
Archives of general psychiatry 1989;46(4):353-8.
1989: M B Stein; Thomas W Uhde
Infrequent occurrence of EEG abnormalities in panic disorder.
The American journal of psychiatry 1989;146(4):517-20.
1989: Thomas A Mellman; Thomas W Uhde
Electroencephalographic sleep in panic disorder. A focus on sleep-related panic attacks.
Archives of general psychiatry 1989;46(2):178-84.
1989: M B Stein; Thomas W Uhde
Autoimmune thyroiditis and panic disorder.
The American journal of psychiatry 1989;146(2):259-60.
1989: M B Stein; C A Shea; Thomas W Uhde
Social phobic symptoms in patients with panic disorder: practical and theoretical implications.
The American journal of psychiatry 1989;146(2):235-8.
1989: Thomas W Uhde; M B Stein; B J Vittone; L J Siever; J P Boulenger; E Klein; Thomas A Mellman
Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder.
Archives of general psychiatry 1989;46(2):170-7.
1988: Peter P Roy-Byrne; S C Risch; Thomas W Uhde
Neuroendocrine effects of diazepam in normal subjects following brief painful stress.
Journal of clinical psychopharmacology 1988;8(5):331-5.
1988: Thomas W Uhde; M B Stein; R M Post
Lack of efficacy of carbamazepine in the treatment of panic disorder.
The American journal of psychiatry 1988;145(9):1104-9.
1988: Robert M Post; P P Roy-Byrne; Thomas W Uhde
Graphic representation of the life course of illness in patients with affective disorder.
The American journal of psychiatry 1988;145(7):844-8.
1988: M B Stein; Thomas W Uhde
Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls.
Biological psychiatry 1988;24(3):322-30.
1988: M B Stein; Thomas W Uhde
Thyroid indices in panic disorder.
The American journal of psychiatry 1988;145(6):745-7.
1988: M B Stein; Thomas W Uhde
Panic disorder and major depression. A tale of two syndromes.
The Psychiatric clinics of North America 1988;11(2):441-61.
1988: M B Stein; Thomas W Uhde
Routine screening of thyroid indices in patients with panic attacks.
The Journal of clinical psychiatry 1988;49(5):204-5.
1988: Thomas W Uhde; Manuel Tancer; C A Shea
Sexual dysfunction related to alprazolam treatment of social phobia.
The American journal of psychiatry 1988;145(4):531-2.
1988: E Klein; Thomas W Uhde
Controlled study of verapamil for treatment of panic disorder.
The American journal of psychiatry 1988;145(4):431-4.
1988: Thomas W Uhde; R T Joffe; D C Jimerson; R M Post
Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
Biological psychiatry 1988;23(6):575-85.
1988: Peter P Roy-Byrne; R M Post; CH Kellner; R T Joffe; Thomas W Uhde
Ventricular-brain ratio and life course of illness in patients with affective disorder.
Psychiatry research 1988;23(3):277-84.
1988: E Klein; Thomas W Uhde
24-hour motor activity in genetically nervous and normal pointer dogs.
Biological psychiatry 1988;23(5):523-7.
1988: Peter P Roy-Byrne; Thomas W Uhde
Exogenous factors in panic disorder: clinical and research implications.
The Journal of clinical psychiatry 1988;49(2):56-61.
1988: E Klein; S A Steinberg; S R Weiss; D M Matthews; Thomas W Uhde
The relationship between genetic deafness and fear-related behaviors in nervous pointer dogs.
Physiology & behavior 1988;43(3):307-12.
1988: E Klein; RH Lenox; Thomas W Uhde
Alpha-2 adrenergic receptor binding in platelets and brains of nervous and normal pointer dogs.
Journal of psychiatric research 1988;22(4):241-7.
1987: Thomas A Mellman; Thomas W Uhde
Obsessive-compulsive symptoms in panic disorder.
The American journal of psychiatry 1987;144(12):1573-6.
1987: E Klein; P J Marangos; P Montgomery; J Bacher; Thomas W Uhde
Adenosine receptor alterations in nervous pointer dogs: a preliminary report.
Clinical neuropharmacology 1987;10(5):462-9.
1987: Robert M Post; Thomas W Uhde; David Rubinow; T Huggins
Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications.
Psychiatry research 1987;22(1):11-9.
1987: R T Joffe; Thomas W Uhde; R M Post; M D Minichiello
Motor activity in depressed patients treated with carbamazepine.
Biological psychiatry 1987;22(8):941-6.
1987: J P Boulenger; N Salem; P J Marangos; Thomas W Uhde
Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeine.
Psychiatry research 1987;21(3):247-55.
1987: R M Post; L E DeLisi; Henry H Holcomb; Thomas W Uhde; R Cohen; Monte Buchsbaum
Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography.
Biological psychiatry 1987;22(5):545-53.
1987: R M Post; Thomas W Uhde; P P Roy-Byrne; R T Joffe
Correlates of antimanic response to carbamazepine.
Psychiatry research 1987;21(1):71-83.
1987: Thomas W Uhde; CH Kellner
Cerebral ventricular size in panic disorder.
Journal of affective disorders 1987;12(2):175-8.
1987: J P Boulenger; Thomas W Uhde
[Acute anxiety attacks and phobia. Historical aspects and clinical manifestations of the agoraphobia syndrome].
Annales médico-psychologiques 1987;145(2):113-31.
1987: Thomas W Uhde; W H Berrettini; P P Roy-Byrne; J P Boulenger; R M Post
Platelet [3H]imipramine binding in patients with panic disorder.
Biological psychiatry 1987;22(1):52-8.
1987: P P Roy-Byrne; Thomas W Uhde; Henry H Holcomb; K Thompson; A K King; H Weingartner
Effects of diazepam on cognitive processes in normal subjects.
Psychopharmacology 1987;91(1):30-3.
1987: P Roy-Byrne; M Geraci; Thomas W Uhde
Life events obtained via interview: the effect of time of recall on data obtained in controls and patients with panic disorder.
Journal of affective disorders 1987;12(1):57-62.
1986: P P Roy-Byrne; M Geraci; Thomas W Uhde
Life events and the onset of panic disorder.
The American journal of psychiatry 1986;143(11):1424-7.
1986: Thomas A Mellman; Thomas W Uhde
Withdrawal syndrome with gradual tapering of alprazolam.
The American journal of psychiatry 1986;143(11):1464-6.
1986: L J Siever; Thomas W Uhde; D C Jimerson; C R Lake; I J Kopin; D L Murphy
Indices of noradrenergic output in depression.
Psychiatry research 1986;19(1):59-73.
1986: P P Roy-Byrne; Thomas W Uhde; R M Post
Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls.
Archives of general psychiatry 1986;43(9):895-9.
1986: Thomas W Uhde; B J Vittone; L J Siever; W H Kaye; R M Post
Blunted growth hormone response to clonidine in panic disorder patients.
Biological psychiatry 1986;21(11):1081-5.
1986: P P Roy-Byrne; M Geraci; Thomas W Uhde
Life events and course of illness in patients with panic disorder.
The American journal of psychiatry 1986;143(8):1033-5.
1986: P P Roy-Byrne; Thomas W Uhde; D A Sack; M Linnoila; R M Post
Plasma HVA and anxiety in patients with panic disorder.
Biological psychiatry 1986;21(8-9):849-53.
1986: P P Roy-Byrne; Thomas W Uhde; R M Post; W Gallucci; G P Chrousos; P W Gold
The corticotropin-releasing hormone stimulation test in patients with panic disorder.
The American journal of psychiatry 1986;143(7):896-9.
1986: Alfred J Lewy; L J Siever; Thomas W Uhde; Sanford Markey
Clonidine reduces plasma melatonin levels.
The Journal of pharmacy and pharmacology 1986;38(7):555-6.
1986: R T Joffe; R M Post; Thomas W Uhde
Effect of carbamazepine on body weight in affectively ill patients.
The Journal of clinical psychiatry 1986;47(6):313-4.
1986: R T Joffe; R M Post; Thomas W Uhde
Effects of carbamazepine on serum electrolytes in affectively ill patients.
Psychological medicine 1986;16(2):331-5.
1986: R M Post; David Rubinow; Thomas W Uhde; J C Ballenger; M Linnoila
Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness.
Archives of general psychiatry 1986;43(4):392-6.
1986: P P Roy-Byrne; Thomas W Uhde; David Rubinow; R M Post
Reduced TSH and prolactin responses to TRH in patients with panic disorder.
The American journal of psychiatry 1986;143(4):503-7.
1986: M S Kafka; J I Nurnberger; L Siever; S Targum; Thomas W Uhde; E S Gershon
Alpha 2-adrenergic receptor function in patients with unipolar and bipolar affective disorders.
Journal of affective disorders 1986;10(2):163-9.
1986: E Klein; Thomas W Uhde; R M Post
Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
The American journal of psychiatry 1986;143(2):235-6.
1986: R Post; Thomas W Uhde; K Kramlinger; David Rubinow
Carbamazepine treatment of mania: clinical and biochemical aspects.
Clinical neuropharmacology 1986;9 Suppl 4():547-9.
1986: R M Post; Thomas W Uhde; P P Roy-Byrne; R T Joffe
Antidepressant effects of carbamazepine.
The American journal of psychiatry 1986;143(1):29-34.
1986: David Rubinow; R M Post; P W Gold; Thomas W Uhde
Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness.
Psychopharmacology 1986;88(1):115-8.
1986: R M Post; F Putnam; Thomas W Uhde; S R Weiss
Electroconvulsive therapy as an anticonvulsant. Implications for its mechanism of action in affective illness.
Annals of the New York Academy of Sciences 1986;462():376-88.
1985: B J Vittone; Thomas W Uhde
Differential diagnosis and treatment of panic disorder: a medical model perspective.
The Australian and New Zealand journal of psychiatry 1985;19(4):330-41.
1985: R M Post; Thomas W Uhde
Are the psychotropic effects of carbamazepine in manic-depressive illness mediated through the limbic system?
Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Université d'Ottawa 1985;10(4):205-19.
1985: Thomas W Uhde; J D Maser
NIMH report. Current perspectives on panic disorder and agoraphobia.
Hospital & community psychiatry 1985;36(11):1153-4.
1985: P P Roy-Byrne; L M Bierer; Thomas W Uhde
The dexamethasone suppression test in panic disorder: comparison with normal controls.
Biological psychiatry 1985;20(11):1237-40.
1985: R T Joffe; R M Post; P P Roy-Byrne; Thomas W Uhde
Hematological effects of carbamazepine in patients with affective illness.
The American journal of psychiatry 1985;142(10):1196-9.
1985: R T Joffe; D W Blank; R M Post; Thomas W Uhde
Decreased triiodothyronines in depression: a preliminary report.
Biological psychiatry 1985;20(8):922-5.
1985: R T Joffe; R M Post; Thomas W Uhde
Lack of pharmacokinetic interaction of carbamazepine with tranylcypromine.
Archives of general psychiatry 1985;42(7):738.
1985: Thomas W Uhde; L M Bierer; R M Post
Caffeine-induced escape from dexamethasone suppression.
Archives of general psychiatry 1985;42(7):737-8.
1985: P P Roy-Byrne; Thomas W Uhde
Panic disorder and major depression: biological relationships.
Psychopharmacology bulletin 1985;21(3):551-4.
1985: Thomas W Uhde; J P Boulenger; P P Roy-Byrne; Marilla Geraci; B J Vittone; Robert M Post
Longitudinal course of panic disorder: clinical and biological considerations.
Progress in neuro-psychopharmacology & biological psychiatry 1985;9(1):39-51.
1985: R M Post; Thomas W Uhde
Carbamazepine in bipolar illness.
Psychopharmacology bulletin 1985;21(1):10-7.
1985: P P Roy-Byrne; Thomas W Uhde; P W Gold; David Rubinow; R M Post
Neuroendocrine abnormalities in panic disorder.
Psychopharmacology bulletin 1985;21(3):546-50.
1985: P Roy-Byrne; R M Post; Thomas W Uhde; T Porcu; D Davis
The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH.
Acta psychiatrica Scandinavica. Supplementum 1985;317():1-34.
1985: P Roy-Byrne; Thomas W Uhde; R M Post; A C King; M S Buchsbaum
Normal pain sensitivity in patients with panic disorder.
Psychiatry research 1985;14(1):77-84.
1985: R M Post; David Rubinow; Thomas W Uhde; J C Ballenger; C R Lake; M Linnoila; D C Jimerson; V Reus
Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients.
Psychopharmacology 1985;87(1):59-63.
1985: M S Kafka; L J Siever; J I Nurnberger; Thomas W Uhde; S Targum; D M Cooper; D P van Kammen; N S Tokola
Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia.
Psychopharmacology bulletin 1985;21(3):599-602.
1985: L J Siever; Thomas W Uhde; Thomas R Insel; W H Kaye; D C Jimerson; C R Lake; M Kafka; S Targum; D L Murphy
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders.
Progress in neuro-psychopharmacology & biological psychiatry 1985;9(1):15-24.
1985: R T Joffe; David Rubinow; R M Post; Thomas W Uhde
Relationship between cerebrospinal fluid somatostatin and peripheral thyroid hormones with carbamazepine treatment.
Neuropsychobiology 1985;14(3):115-7.
1984: P P Roy-Byrne; R T Joffe; Thomas W Uhde; R M Post
Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications.
Archives of general psychiatry 1984;41(12):1150-3.
1984: J P Boulenger; Thomas W Uhde; E A Wolff; R M Post
Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence.
Archives of general psychiatry 1984;41(11):1067-71.
1984: Thomas W Uhde; B J Vittone; R M Post
Glucose tolerance testing in panic disorder.
The American journal of psychiatry 1984;141(11):1461-3.
1984: P P Roy-Byrne; R T Joffe; Thomas W Uhde; R M Post
Approaches to the evaluation and treatment of rapid-cycling affective illness.
The British journal of psychiatry : the journal of mental science 1984;145():543-50.
1984: R T Joffe; CH Kellner; R M Post; Thomas W Uhde
Lithium increases platelet count.
The New England journal of medicine 1984;311(10):674-5.
1984: R M Post; W Berrettini; Thomas W Uhde; CH Kellner
Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study.
Journal of clinical psychopharmacology 1984;4(4):178-85.
1984: Thomas W Uhde; P Roy-Byrne; J C Gillin; W B Mendelson; J P Boulenger; B J Vittone; Robert M Post
The sleep of patients with panic disorder: a preliminary report.
Psychiatry research 1984;12(3):251-9.
1984: R T Joffe; P W Gold; Thomas W Uhde; R M Post
The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone.
Psychiatry research 1984;12(2):161-6.
1984: L J Siever; Thomas W Uhde; D C Jimerson; C R Lake; E R Silberman; R M Post; D L Murphy
Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
The American journal of psychiatry 1984;141(6):733-41.
1984: P Roy-Byrne; Thomas W Uhde; R M Post; R T Joffe
Relationship of response to sleep deprivation and carbamazepine in depressed patients.
Acta psychiatrica Scandinavica 1984;69(5):379-82.
1984: R M Post; Thomas W Uhde
Carbamazepine and lithium carbonate synergism in mania.
Archives of general psychiatry 1984;41(2):210.
1984: L J Siever; Thomas W Uhde
New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
Biological psychiatry 1984;19(2):131-56.
1984: L J Siever; Thomas W Uhde; D C Jimerson; R M Post; C R Lake; D L Murphy
Plasma cortisol responses to clonidine in depressed patients and controls. Evidence for a possible alteration in noradrenergic-neuroendocrine relationships.
Archives of general psychiatry 1984;41(1):63-8.
1984: Thomas W Uhde; J P Boulenger; Robert M Post; L J Siever; B J Vittone; D C Jimerson; P P Roy-Byrne
Fear and anxiety: relationship to noradrenergic function.
Psychopathology 1984;17 Suppl 3():8-23.
1984: David Rubinow; R M Post; P W Gold; Thomas W Uhde
Neuroendocrine and peptide effects of carbamazepine: clinical and mechanistic implications.
Psychopharmacology bulletin 1984;20(3):590-4.
1984: R M Post; David Rubinow; Thomas W Uhde
Biochemical mechanisms of action of carbamazepine in affective illness and epilepsy.
Psychopharmacology bulletin 1984;20(3):585-9.
1984: Thomas W Uhde; J P Boulenger; D C Jimerson; R M Post
Caffeine: relationship to human anxiety, plasma MHPG and cortisol.
Psychopharmacology bulletin 1984;20(3):426-30.
1984: R M Post; Thomas W Uhde; J C Ballenger
The efficacy of carbamazepine in affective illness.
Advances in biochemical psychopharmacology 1984;39():421-37.
1984: R M Post; Thomas W Uhde; E A Wolff
Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite.
Acta psychiatrica Scandinavica. Supplementum 1984;313():104-20.
1984: J P Boulenger; P J Marangos; J Patel; Thomas W Uhde; R M Post
Central adenosine receptors: possible involvement in the chronic effects of caffeine.
Psychopharmacology bulletin 1984;20(3):431-5.
1983: R M Post; Thomas W Uhde; J C Ballenger; K M Squillace
Prophylactic efficacy of carbamazepine in manic-depressive illness.
The American journal of psychiatry 1983;140(12):1602-4.
1983: P Roy-Byrne; B J Vittone; Thomas W Uhde
Alprazolam-related hepatotoxicity.
Lancet 1983;2(8353):786-7.
1983: R M Post; Thomas W Uhde; J C Ballenger; D C Chatterji; R F Greene; W E Bunney
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response.
Archives of general psychiatry 1983;40(6):673-6.
1983: Thomas W Uhde; R M Post
Effects of carbamazepine on serum electrolytes: clinical and theoretical implications.
Journal of clinical psychopharmacology 1983;3(2):103-6.
1983: L J Siever; Thomas R Insel; D C Jimerson; C R Lake; Thomas W Uhde; J Aloi; D L Murphy
Growth hormone response to clonidine in obsessive-compulsive patients.
The British journal of psychiatry : the journal of mental science 1983;142():184-7.
1983: L J Siever; DAVID PICKAR; C R Lake; R M Cohen; Thomas W Uhde; D L Murphy
Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports.
Journal of clinical psychopharmacology 1983;3(1):39-41.
1983: L J Siever; Thomas W Uhde; Thomas R Insel; W H Kaye; D C Jimerson; C R Lake; M Kafka; S Targum; L Murphy
Abnormalities in the primary affective disorders compared to other tricyclic-responsive disorders.
Psychopharmacology bulletin 1983;19(3):435-6.
1983: R M Post; Thomas W Uhde
Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications.
Epilepsia 1983;24 Suppl 2():S97-108.
1983: J P Boulenger; Thomas W Uhde
[Treatment of panic attacks].
L'Encéphale 1983;9(4 Suppl 2):299B-305B.
1983: L J Siever; Thomas W Uhde; D C Jimerson; M S Kafka; C R Lake; S Targum; D L Murphy
Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment.
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(2-3):249-61.
1983: R M Post; Thomas W Uhde; David Rubinow; J C Ballenger; P W Gold
Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness.
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(2-3):263-71.
1982: J P Boulenger; Thomas W Uhde
[Biochemical aspects of anxiety].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1982;58(44):2573-9.
1982: R M Post; Thomas W Uhde; F W Putnam; J C Ballenger; W H Berrettini
Kindling and carbamazepine in affective illness.
The Journal of nervous and mental disease 1982;170(12):717-31.
1982: J P Boulenger; Thomas W Uhde
Caffeine consumption and anxiety: preliminary results of a survey comparing patients with anxiety disorders and normal controls.
Psychopharmacology bulletin 1982;18(4):53-7.
1982: Thomas W Uhde; J P Boulenger; L J Siever; R L DuPont; R M Post
Animal models of anxiety: implications for research in humans.
Psychopharmacology bulletin 1982;18(4):47-52.
1982: Thomas W Uhde; L J Siever; R M Post; D C Jimerson; J P Boulenger; Monte Buchsbaum
The relationship of plasma free MHPG to anxiety and psycho-physical pain in normal volunteers.
Psychopharmacology bulletin 1982;18(4):129-32.
1982: Alfred J Lewy; Thomas Wehr; N E Rosenthal; J I Nurnberger; L J Siever; Thomas W Uhde; D A Newsome; L E Becker; Sanford Markey; I J Kopin; F K Goodwin
Melatonin secretion as a neurobiological "marker" and effects of light in humans.
Psychopharmacology bulletin 1982;18(4):127-9.
1982: L J Siever; Thomas W Uhde; Thomas R Insel; B F Roy; D L Murphy
Growth hormone response to clonidine unchanged by chronic clorgyline treatment.
Psychiatry research 1982;7(2):139-44.
1982: L J Siever; Thomas W Uhde; E K Silberman; C R Lake; D C Jimerson; S C Risch; N H Kalin; D L Murphy
Evaluation of alpha-adrenergic responsiveness to clonidine challenge and noradrenergic metabolism in the affective disorders and their treatment.
Psychopharmacology bulletin 1982;18(4):118-9.
1982: R M Post; J C Ballenger; Thomas W Uhde; C Smith; David Rubinow; W E Bunney
Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness.
Biological psychiatry 1982;17(9):1037-45.
1982: Thomas W Uhde; D E Redmond; H D Kleber
Psychosis in the opioid addicted patient: assessment and treatment.
The Journal of clinical psychiatry 1982;43(6):240-7.
1982: L J Siever; Thomas W Uhde; D L Murphy
Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients.
Psychiatry research 1982;6(3):293-302.
1982: L J Siever; Thomas W Uhde; E K Silberman; D C Jimerson; J A Aloi; R M Post; D L Murphy
Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls.
Psychiatry research 1982;6(2):171-83.
1982: J P Boulenger; Thomas W Uhde
Biological peripheral correlates of anxiety.
L'Encéphale 1982;8(2):119-30.
1982: R M Post; Thomas W Uhde
Biological relationships between mania and melancholia.
L'Encéphale 1982;8(2):213-28.
1981: R M Post; DAVID PICKAR; D Naber; J C Ballenger; Thomas W Uhde; W E Bunney
Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response.
Psychiatry research 1981;5(1):59-66.
1981: L Siever; Thomas R Insel; Thomas W Uhde
Noradrenergic challenges in the affective disorders.
Journal of clinical psychopharmacology 1981;1(4):193-206.
1980: Thomas W Uhde; R M Post; L J Siever; Monte Buchsbaum
Clonidine and psychophysical pain.
Lancet 1980;2(8208-8209):1375.
1980: Thomas W Uhde; D E Redmond; H D Kleber
Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study.
Psychiatry research 1980;2(1):37-47.
1980: M S Kafka; D P van Kammen; J E Kleinman; J I Nurnberger; L J Siever; Thomas W Uhde; R J Polinsky
Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases.
Communications in psychopharmacology 1980;4(6):477-86.